Oxford Drug Design Validates Novel Oncology Therapeutic Mechanism
Oxford Drug Design, an AI-driven drug discovery company, has achieved successful in vivo validation of its novel oncology therapeutic mechanism …
All Posts
Bioptimus Introduces H-optimus-0: An Open-Source AI Model for Pathology
French startup Bioptimus has released H-optimus-0, the largest open-source AI foundation model for pathology. With 1.1 billion parameters, this model …
A Growing Race to Change Status Quo in the Lucrative NGS Market
Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA …
Gene-Editing Tool Modifies Gut Bacteria in Living Mice
Researchers have developed a new gene-editing tool capable of modifying bacterial populations within the gut microbiome of living mice. This …
Lantern Pharma Advances Development of Molecular Diagnostic for Oncology Clinical Trials
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company, has reached a milestone in the development of a diagnostic tool for …
Concr Launches VISION Trial Using Digital Twins for Predicting Breast Cancer Outcomes
Concr has initiated the recruitment of patients for the VISION trial, an observational clinical study designed to evaluate Concr's predictive …
Advances in LBP Manufacturing: Microbiotica and Biose Industrie Prepare for Clinical Studies
Microbiotica, a biotechnology firm focused on developing precision microbiome medicines known as live biotherapeutic products (LBPs), is preparing for clinical …
Biostate AI Launches RNA Sequencing and Data Analysis Services
Biostate AI, a startup focused on scalable biodata solutions, has launched two new service products aimed at advancing multiomic data …
Light-weight Microscope Captures Large-scale Brain Activity in Freely Moving Mice
Researchers at Rockefeller University have developed a new lightweight microscope capable of capturing large-scale brain activity in mice while they …
Myricx Bio Secures £90m Series A Funding to Progress NMTi-ADC Therapeutics into Clinical Trials
Myricx Bio, a UK-based biotechnology company specializing in novel antibody-drug conjugates (ADCs), has raised £90 million ($114 million) in a …
FDA Approves Signet Therapeutics' IND Application for sigx1094 in Diffuse Gastric Cancer
Signet Therapeutics, a biotechnology company specializing in targeted cancer therapy, has received FDA approval for its Investigational New Drug (IND) …
OMNY Health Partners with QuantHealth and ArisGlobal to Enhance AI-Driven Healthcare Solutions
OMNY Health, a healthcare ecosystem specializing in compliant cross-industry data sharing, has launched a platform designed to support AI-driven health …